P
ProKidney Corp. (PROK)
NCM – Real Time Price. Currency in USD
1.83
+0.13 (7.65%)
At close: Jun 26, 2026, 4:00 PM EDT
1.82
-0.01 (-0.55%)
After-hours: Jun 26, 2026, 7:21 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.83
+0.13 (7.65%)
At close: Jun 26, 2026, 4:00 PM EDT
1.82
-0.01 (-0.55%)
After-hours: Jun 26, 2026, 7:21 PM EDT
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
| Name | Position |
|---|---|
| Dr. Bruce Culleton M.D. | CEO & Director |
| Dr. Darin J. Weber Ph.D. | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access |
| Dr. Emily Butler Ph.D. | Senior VP of Biometric |
| Dr. Joseph M. Stavas M.D., M.P.H. | SVP of Clinical Affairs |
| Dr. Ulrich Ernst Ph.D. | EVP of Science and Technology |
| Mr. James Coulston CPA | Chief Financial Officer |
| Mr. Kenneth Locke | Chief Technical Officer |
| Mr. Richard Williams | Chief Information Officer |
| Mr. Todd C. Girolamo Esq., J.D., M.B.A. | Chief Legal Officer & Secretary |
| Ms. Carla Poulson | Chief People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-29 | 8-K | prok-20260528.htm |
| 2026-05-15 | 8-K | prok-20260515.htm |
| 2026-05-15 | 10-Q | prok-20260331.htm |
| 2026-04-17 | DEFA14A | ny20066059x2_defa14a.htm |
| 2026-04-17 | DEF 14A | ny20066059x1_def14a.htm |
| 2026-04-17 | ARS | ny20066059x3_ars.pdf |
| 2026-03-18 | S-8 | prok-20260318.htm |
| 2026-03-18 | 10-K | prok-20251231.htm |
| 2026-02-02 | 8-K | prok-20260202.htm |
| 2026-01-12 | 8-K | prok-20260112.htm |